4
Changes in Ownership
Lyell Immunopharma, Inc. Filed Acc 0001209191-22-020001
Options or other derivatives
- Chief Technical Ops. Officer acquired 700,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Hill Stephen J. · Chief Technical Ops. Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2022-03-16 | Grant or award : show line 1 in the form Option (right to buy) | +700,000 | $5.98 | 2032-03-15 | 700,000 | 700,000 | D |
Loading xslF345X03/doc4.xml…